neuro-primary-mental-health-2017-scientifictracks

Page 24

Notes:

allied

academies

International Conference on

NEUROLOGY AND NEUROSCIENCE

MENTAL HEALTH AND PRIMARY CARE

October 16-18, 2017 | Toronto, Canada

J Neurol Neurorehabil Res 2017 | Volume 2 Issue 3

Primitive social rank and assertiveness disorders: Towards a new model of neurobehavioral therapy

for psychotic disorders

Camille Lefrançois

Funds of Environmental Medicine Institute (Fonds Institut de Médecine Environnementale), France

everal studies and observations tend to highlight

one continuum between an excess and a lack of self-

confidence, and a second one between an excess and a lack of

trust in others. Theory suggests that these types of behaviors

are like vestiges of a primitive social rank and positioning

relative to the group. Some of these behaviors could be

involved and even take an active part in particular troubles

as social phobia and anxiety, self-harm, depression, or at

the opposite in antisocial personality disorder, oppositional

defiant disorders, bullying, lack of assertiveness, narcissistic

perversion, paranoia, etc. According to this point of view,

the authors have experimented new role-playing exercises

of acting as an antidote to the positioning of the individual

relative to the group. This presentation exposes the details

of the theory (neurological assumptions, autoregulation of

these dynamics) and the different observations, precautions

and results of this type of therapy, when considering adult

and childhood cases. The effects of these skills concern

the symptoms which appear in social anxiety, depression,

obsessive and compulsive disorders, bullying and antisocial

personality disorder.

Speaker Biography

Camille Lefrançois is a Psychologist and Researcher in the domain of Neurocognitive

and Behavioral Therapy. She has her expertise in improving mental health and

wellbeing. Her research is about new models of understanding human neurocognition

and behaviors, and psychiatric disorders. Her goal is to create and evaluate new

therapeutic tools.